Cellular distribution of endothelin-converting enzyme-1 in human tissues

Citation
P. Korth et al., Cellular distribution of endothelin-converting enzyme-1 in human tissues, J HIST CYTO, 47(4), 1999, pp. 447-461
Citations number
52
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
ISSN journal
00221554 → ACNP
Volume
47
Issue
4
Year of publication
1999
Pages
447 - 461
Database
ISI
SICI code
0022-1554(199904)47:4<447:CDOEEI>2.0.ZU;2-J
Abstract
Endothelin-converting enzyme-1 (ECE-1) is the key enzyme of endothelin bios ynthesis, catalyzing the final processing step. As shown by the targeted di sruption of the ECE-1 gene, mature endothelins must be produced at specific sites for normal embryonic development. Therefore, it is important to know the exact pattern of ECE-1 gene expression. In this study we investigated the cellular distribution of ECE-1 in a variety of human tissues by in situ hybridization and immunohistochemistry. Widespread expression of the ECE-1 gene was noted, with a similar distribution pattern for mRNA and protein i n normal human tissues, suggesting a major biological role for ECE-1. ECE-1 levels were particularly high in the cardiovascular, reproductive, and end ocrine systems. There was strong and consistent labeling for ECE-1 in the v ascular endothelial cells of all organs examined and in various nonvascular cells, especially some glandular cells. A large amount of ECE-1 protein an d mRNA was detected in the Leydig cells of the testis and in the granulosa and theca cells of the ovary. In the adrenal gland, ECE-1 was detected in t he cortex and medulla, with the strongest labeling in the zona glomerulosa. Therefore, ECE-1 may be involved in other systems, such as the regulation of hormone secretion, rather than exclusively generating ET-1 from its prec ursor. These results point out the potential side effects of ECE-1 inhibito rs that are currently under development for treatment of cardiovascular dis eases.